NPR logo

Oregon, Washington, Idaho Part Of Multi-State Pharmaceutical Settlement

  • Download
  • <iframe src="https://www.npr.org/player/embed/165240538/165240556" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
Oregon, Washington, Idaho Part Of Multi-State Pharmaceutical Settlement

Politics

Oregon, Washington, Idaho Part Of Multi-State Pharmaceutical Settlement

Oregon, Washington, Idaho Part Of Multi-State Pharmaceutical Settlement

  • Download
  • <iframe src="https://www.npr.org/player/embed/165240538/165240556" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

Oregon, Washington and Idaho are part of a $90 million, 38 state settlement announced Thursday with pharmaceutical giant GlaxoSmithKline. The lawsuit claims the drug company downplayed the cardiovascular risks of the diabetes drug Avandia , which has been linked to an increased risk of heart attacks.

It's the third major pharmaceutical settlement announced by Oregon Attorney General Ellen Rosenblum since she took office in June. Each case began under her predecessor, John Kroger.

But Justice Department spokesman, Jeff Manning, says the Attorney General will continue going after drug companies.

"When you're talking about a giant pharmaceutical company misrepresenting the safety aspects of a widely-marketed drug, that is right in the wheelhouse of the Department of Justice."

No Alternative Text

Oregon Attorney General Ellen Rosenblum has announced a third major pharmaceutical settlement since she took office. hide caption

toggle caption

As one of the lead plaintiffs, Oregon gets a larger share of the settlement. Manning says the state has recovered more than $18 million from pharmaceutical companies in the past two years.

Copyright 2012 Northwest News Network

We no longer support commenting on NPR.org stories, but you can find us every day on Facebook, Twitter, email, and many other platforms. Learn more or contact us.